✦ LIBER ✦

2LBA Denosumab versus zoledronic acid for the treatment of breast cancer patients with bone metastases: results of a randomized phase 3 study

✍ Scribed by A. Stopeck; J.J. Body; Y. Fujiwara; A. Lipton; G.G. Steger; M. Viniegra; M. Fan; A. Braun; R. Dansey; S. Jun

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of a prospective, randomized, do

✍ Jean-Jacques Body; Alison Stopeck; Yasuhiro Fujiwara; Allan Lipton; Guenther Ste 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 71 KB

20LBA A double-blind, randomized study o

✍ D. Henry; R. von Moos; S. Vadhan-Raj; V. Hungria; A. Spencer; V. Hirsh; J. Wang; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Denosumab versus zoledronic acid in pati

✍ J. Brown*; M. Carducci; K. Fizazi; M. Smith; R. Damião; L. Karsh; P. Milecki; H. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Denosumab versus zoledronic acid (ZA) fo

✍ A. Lipton*; A. Stopeck; R. von Moos; D. Henry; G. Richardson; G. Rodriguez; H. B 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 48 KB

AOSOP6 Results from the 2-year open-labe

✍ A.T. Stopeck; A. Lipton; M. Martín; J-J. Body; A. Paterson; G.G. Steger; K. Tonk 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Pain outcomes in patients with advanced

✍ Charles S. Cleeland; Jean-Jacques Body; Alison Stopeck; Roger von Moos; Lesley F 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 346 KB